Literature DB >> 19025916

Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation.

Norma C McAvoy1, Narendra Kochar, Graham McKillop, David E Newby, Peter C Hayes.   

Abstract

Patients with advanced liver disease are at increased risk of cardiovascular events, especially following orthotopic liver transplantation (OLT). Coronary artery calcification (CAC) is a novel and independent predictor of cardiovascular risk, but its prevalence and utility in patients with cirrhosis are unknown. The aim of this study was to define the prevalence of CAC and its association with markers of disease severity and standard measures of cardiovascular risk in a large cohort of patients undergoing OLT assessment. A single-center, prospective, observational study of 147 consecutive patients undergoing assessment for OLT was performed. CAC scores were derived with the Agatston method from thoracic computed tomography scans and correlated with cardiovascular risk factors and measures of liver disease severity. There were 101 patients (66 males) with a mean age of 53.2 years; 46 patients were excluded because the CAC score was not reported. The median CAC score was 40 HU (range, 0-3533). Correlations were identified between the CAC score and age (r = 0.477; P < 0.001), male sex (r = 0.262; P = 0.008), family history of cardiovascular disease (r = 0.208; P = 0.036), Framingham risk score (r = 0.621; P < 0.001), Model for End-Stage Liver Disease score (r = 0.221; P = 0.027), systolic blood pressure (r = 0.285; P = 0.004), diastolic blood pressure (r = 0.267; P = 0.007), cytomegalovirus status (r = 0.278; P = 0.005), fasting glucose (r = 0.330; P = 0.001), number of coronary vessels involved (r = 0.899; P < 0.001), and components of the metabolic syndrome (r = 0.226; P = 0.026). After multivariate analysis, age, systolic blood pressure, fasting glucose, number of features of metabolic syndrome, and number of vessels involved remained significantly associated with CAC. In conclusion, this study identified a high prevalence of occult coronary artery disease in patients undergoing OLT assessment and identified a strong relationship between CAC scores and a limited number of specific cardiovascular risk factors. The usefulness of these factors in predicting perioperative and postoperative cardiovascular events in patients undergoing OLT requires prospective evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 19025916     DOI: 10.1002/lt.21540

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

Review 1.  Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

Authors:  Robert J Donovan; Calvin Choi; Asghar Ali; Douglas M Heuman; Michael Fuchs; Anthony A Bavry; Ion S Jovin
Journal:  Dig Dis Sci       Date:  2016-11-09       Impact factor: 3.199

2.  Low yield of routine stress testing in patients awaiting liver transplantation.

Authors:  Cigdem Akincioglu; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2018-08-30       Impact factor: 5.952

Review 3.  Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.

Authors:  Kalindi Parikh; Andrew Appis; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-10-08       Impact factor: 5.952

4.  Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Authors:  Karen V Danielsen; Signe Wiese; Jens Hove; Flemming Bendtsen; Søren Møller
Journal:  Dig Dis Sci       Date:  2018-03-08       Impact factor: 3.199

Review 5.  Evaluation of liver transplant candidates with non-alcoholic steatohepatitis.

Authors:  James Philip G Esteban; Amon Asgharpour
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

6.  Moving toward the utilization of all donated liver grafts. The "b-list" concept.

Authors:  D Vrochides; P Metrakos
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

7.  The predictors of post-transplant coronary events among liver transplant recipients.

Authors:  Mohammad U Malik; Stuart D Russell; Aliaksei Pustavoitau; Matthews Chacko; Arif M Cosar; Carol B Thompson; Panagiotis Trilianos; Nabil N Dagher; Andrew M Cameron; Ahmet Gurakar
Journal:  Hepatol Int       Date:  2016-06-16       Impact factor: 6.047

8.  Prevalence of myocardial perfusion abnormalities in end-stage liver disease.

Authors:  Ahmed Fathala; Bander Safar; Ahmed Al Muhaideb
Journal:  Indian J Nucl Med       Date:  2011-01

Review 9.  Cardiovascular dysfunction in patients with liver cirrhosis.

Authors:  Giuseppe Fede; Graziella Privitera; Tania Tomaselli; Luisa Spadaro; Francesco Purrello
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

10.  Preoperative cardiovascular investigations in liver transplant candidate: An update.

Authors:  Lalit Sehgal; Piyush Srivastava; Chandra Kant Pandey; Amit Jha
Journal:  Indian J Anaesth       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.